Global Artificial Kidney Market Size, Status and Forecast 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Artificial Kidney Quarterly Market Size Analysis
- 2.1 Artificial Kidney Business Impact Assessment - COVID-19
- 2.1.1 Global Artificial Kidney Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Artificial Kidney Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Artificial Kidney Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Artificial Kidney Headquarters and Area Served
- 3.3 Date of Key Players Enter into Artificial Kidney Market
- 3.4 Key Players Artificial Kidney Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Artificial Kidney Segments, By Type
- 4.1 Introduction
- 1.4.1 Wearable Artificial Kidney
- 1.4.2 Implantable Artificial Kidney
- 4.2 By Type, Global Artificial Kidney Market Size, 2019-2021
5 Impact of Covid-19 on Artificial Kidney Segments, By Application
- 5.1 Overview
- 5.5.1 Adults
- 5.5.2 Pediatrics
- 5.2 By Application, Global Artificial Kidney Market Size, 2019-2021
- 5.2.1 By Application, Global Artificial Kidney Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Kawasumi Laboratories
- 7.1.1 Kawasumi Laboratories Business Overview
- 7.1.2 Kawasumi Laboratories Artificial Kidney Quarterly Revenue, 2020
- 7.1.3 Kawasumi Laboratories Artificial Kidney Product Introduction
- 7.1.4 Kawasumi Laboratories Response to COVID-19 and Related Developments
- 7.2 Fresenius
- 7.2.1 Fresenius Business Overview
- 7.2.2 Fresenius Artificial Kidney Quarterly Revenue, 2020
- 7.2.3 Fresenius Artificial Kidney Product Introduction
- 7.2.4 Fresenius Response to COVID-19 and Related Developments
- 7.3 Baxter
- 7.3.1 Baxter Business Overview
- 7.3.2 Baxter Artificial Kidney Quarterly Revenue, 2020
- 7.3.3 Baxter Artificial Kidney Product Introduction
- 7.3.4 Baxter Response to COVID-19 and Related Developments
- 7.4 Asahi Kasei Medical
- 7.4.1 Asahi Kasei Medical Business Overview
- 7.4.2 Asahi Kasei Medical Artificial Kidney Quarterly Revenue, 2020
- 7.4.3 Asahi Kasei Medical Artificial Kidney Product Introduction
- 7.4.4 Asahi Kasei Medical Response to COVID-19 and Related Developments
- 7.5 Xcorporeal
- 7.5.1 Xcorporeal Business Overview
- 7.5.2 Xcorporeal Artificial Kidney Quarterly Revenue, 2020
- 7.5.3 Xcorporeal Artificial Kidney Product Introduction
- 7.5.4 Xcorporeal Response to COVID-19 and Related Developments
- 7.6 Medtronic
- 7.6.1 Medtronic Business Overview
- 7.6.2 Medtronic Artificial Kidney Quarterly Revenue, 2020
- 7.6.3 Medtronic Artificial Kidney Product Introduction
- 7.6.4 Medtronic Response to COVID-19 and Related Developments
- 7.7 DaVita
- 7.7.1 DaVita Business Overview
- 7.7.2 DaVita Artificial Kidney Quarterly Revenue, 2020
- 7.7.3 DaVita Artificial Kidney Product Introduction
- 7.7.4 DaVita Response to COVID-19 and Related Developments
- 7.8 Merit Medical Systems
- 7.8.1 Merit Medical Systems Business Overview
- 7.8.2 Merit Medical Systems Artificial Kidney Quarterly Revenue, 2020
- 7.8.3 Merit Medical Systems Artificial Kidney Product Introduction
- 7.8.4 Merit Medical Systems Response to COVID-19 and Related Developments
- 7.9 NIPRO Medical Corporation
- 7.9.1 NIPRO Medical Corporation Business Overview
- 7.9.2 NIPRO Medical Corporation Artificial Kidney Quarterly Revenue, 2020
- 7.9.3 NIPRO Medical Corporation Artificial Kidney Product Introduction
- 7.9.4 NIPRO Medical Corporation Response to COVID-19 and Related Developments
- 7.10 Nikkiso
- 7.10.1 Nikkiso Business Overview
- 7.10.2 Nikkiso Artificial Kidney Quarterly Revenue, 2020
- 7.10.3 Nikkiso Artificial Kidney Product Introduction
- 7.10.4 Nikkiso Response to COVID-19 and Related Developments
- 7.11 B. Braun Melsungen AG
- 7.11.1 B. Braun Melsungen AG Business Overview
- 7.11.2 B. Braun Melsungen AG Artificial Kidney Quarterly Revenue, 2020
- 7.11.3 B. Braun Melsungen AG Artificial Kidney Product Introduction
- 7.11.4 B. Braun Melsungen AG Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Artificial Kidney, including the following market information:
Global Artificial Kidney Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Kidney Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Kidney Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Kidney Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal, Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Wearable Artificial Kidney
Implantable Artificial Kidney
Based on the Application:
Adults
Pediatrics